VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $401,470 | +2.5% | 14,919 | +14.7% | 0.00% | 0.0% |
Q2 2023 | $391,580 | +1.2% | 13,005 | +8.7% | 0.00% | 0.0% |
Q1 2023 | $387,068 | +3.1% | 11,965 | -8.6% | 0.00% | 0.0% |
Q4 2022 | $375,302 | +29.0% | 13,095 | +8.6% | 0.00% | 0.0% |
Q3 2022 | $291,000 | -3.0% | 12,062 | +10.3% | 0.00% | 0.0% |
Q2 2022 | $300,000 | -31.7% | 10,940 | -4.5% | 0.00% | 0.0% |
Q1 2022 | $439,000 | +6.0% | 11,460 | -11.5% | 0.00% | 0.0% |
Q4 2021 | $414,000 | -6.3% | 12,942 | -13.7% | 0.00% | 0.0% |
Q3 2021 | $442,000 | -31.0% | 14,992 | -19.0% | 0.00% | 0.0% |
Q2 2021 | $641,000 | -77.2% | 18,508 | -78.5% | 0.00% | -83.3% |
Q1 2021 | $2,814,000 | +49.6% | 86,208 | +65.1% | 0.01% | +50.0% |
Q4 2020 | $1,881,000 | +119.2% | 52,231 | +138.5% | 0.00% | +100.0% |
Q3 2020 | $858,000 | +121.7% | 21,896 | +107.5% | 0.00% | +100.0% |
Q2 2020 | $387,000 | +21.3% | 10,550 | -23.8% | 0.00% | 0.0% |
Q1 2020 | $319,000 | +6.7% | 13,847 | +35.3% | 0.00% | 0.0% |
Q4 2019 | $299,000 | -93.7% | 10,232 | -94.2% | 0.00% | -92.3% |
Q3 2019 | $4,732,000 | +1431.4% | 177,190 | +1365.2% | 0.01% | +1200.0% |
Q2 2019 | $309,000 | +14.0% | 12,093 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $271,000 | +163.1% | 12,093 | +147.5% | 0.00% | – |
Q4 2018 | $103,000 | +14.4% | 4,887 | 0.0% | 0.00% | – |
Q3 2018 | $90,000 | -17.4% | 4,887 | 0.0% | 0.00% | – |
Q2 2018 | $109,000 | -23.2% | 4,887 | -24.5% | 0.00% | – |
Q1 2018 | $142,000 | -81.9% | 6,470 | -80.8% | 0.00% | -100.0% |
Q4 2017 | $783,000 | -6.2% | 33,698 | -7.3% | 0.00% | -33.3% |
Q3 2017 | $835,000 | +11.5% | 36,353 | +7.2% | 0.00% | +50.0% |
Q2 2017 | $749,000 | -2.5% | 33,925 | +0.7% | 0.00% | -33.3% |
Q1 2017 | $768,000 | +8.9% | 33,698 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $705,000 | -39.0% | 33,698 | -22.9% | 0.00% | -25.0% |
Q3 2016 | $1,155,000 | +35.1% | 43,703 | +41.6% | 0.00% | +33.3% |
Q2 2016 | $855,000 | – | 30,873 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |